Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$12.0 - $16.13 $2.18 Million - $2.94 Million
-182,048 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$11.84 - $25.52 $5,813 - $12,530
491 Added 0.27%
182,048 $2.46 Million
Q4 2019

Feb 13, 2020

BUY
$17.72 - $25.1 $335,918 - $475,820
18,957 Added 11.66%
181,557 $4.39 Million
Q3 2019

Nov 14, 2019

BUY
$18.41 - $28.0 $757,295 - $1.15 Million
41,135 Added 33.87%
162,600 $3.13 Million
Q2 2019

Aug 13, 2019

BUY
$28.97 - $48.21 $45,395 - $75,545
1,567 Added 1.31%
121,465 $3.59 Million
Q1 2019

May 14, 2019

BUY
$36.32 - $49.25 $484,472 - $656,945
13,339 Added 12.52%
119,898 $5.7 Million
Q4 2018

Feb 15, 2019

BUY
$33.0 - $60.04 $309,309 - $562,754
9,373 Added 9.64%
106,559 $3.85 Million
Q3 2018

Nov 15, 2018

SELL
$56.15 - $73.9 $657,741 - $865,664
-11,714 Reduced 10.76%
97,186 $5.98 Million
Q2 2018

Aug 14, 2018

BUY
$47.85 - $70.45 $28,183 - $41,495
589 Added 0.54%
108,900 $7.36 Million
Q1 2018

May 08, 2018

BUY
$51.15 - $61.0 $72,172 - $86,071
1,411 Added 1.32%
108,311 $5.88 Million
Q4 2017

Feb 14, 2018

BUY
$50.85 - $65.1 $555,282 - $710,891
10,920 Added 11.38%
106,900 $6.39 Million
Q3 2017

Nov 14, 2017

BUY
$48.6 - $60.1 $4.66 Million - $5.77 Million
95,980
95,980 $4.67 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.